Paul Wardle Email & Phone Number

Toronto, Ontario, CA

• Driving transformative patient/consumer-centric healthcare strategy and innovation. Championing availability, access & adoption of self-directed healthcare solutions for patients and consumers.Clients include.
• Enhancing healthcare brand adoption and retention with strategic solutions to address marketplace needs and behavioral barriers
• Lifecycle management: novel marketing & regulatory strategies, product innovation, claims & technology
• ACNU: Advancing solutions to deliver consumer/patient access through the FDA proposed ACNU rule (Additional Condition for Non-prescription Use)
• Rx-to-OTC switch: best practice & key success factors; labeling & packaging; switch process & behavioral studies; benefit/risk assessment; cross-functional coordination; commercial business planning & brand launch

New York, NY, US

- Statistics, Measurement & Analysis. A graduate marketing course- Healthcare Product and Brand Development: From Discovery to Launch to Brand Building. An elective course in the Certificate in Healthcare Marketing and Communications- Statistics, Measurement & Analysis. A graduate marketing course

Chatillon, IL, FR

• Head of marketing for US women's health portfolioBusiness / product innovation cross-functional lead for R&D, regulatory, and commercializationRx-to-OTC switch program lead (patient/consumer access initiatives): Opill.
• Led cross-functional team - regulatory, clinical, medical, marketing, supply, project management, CRO & KOL experts
• Championed programs, significantly improving business cases & strategic definition
• Generated thorough understanding of the patient journey and consumer path to purchase
• Completed OTC labeling development and behavioral testing, clinical behavioral actual use studies
• Guided numerous FDA interactions. strategy, briefing books, meetings written responses, labelling changes

New York, New York, US

• Led commercial team of 10 and co-lead for cross-functional team of 70 colleagues for $4bn NPV portfolio of lifecycle management initiatives. Managed departmental resource prioritization and budget. Drove global vision.
• Advanced 8 stage-gated global programs (including Lipitor, Viagra and Nexium)
• Synthesized switch best practices for regulatory pathway progress and brand launch
• Championed OTC Viagra Global Brand Strategy, including cross-discipline EU regulatory filing, resulting in highly successful EU launches & program awards.
• Leveraged innovative digital & research tools to generate rich patient journey and HCP insights
• Headed collaboration to fashion global brand guidelines & integrated launch planning toolkits

New York, New York, US

• Established Pfizer global Rx to OTC switch lifecycle management strategy and drove development of governance, switch processes & capabilities.
• Gained corporate alignment for business case and strategy for Pfizer to pursue portfolio of first-in-class switch programs across multiple therapeutic areas: Established cross-business unit governance and.
• Championed program to switch Lipitor, the world’s largest prescription brand: Led complex cross-business unit analysis, planning, issues management strategy and novel OTC labeling development. Resulted in successful.

New York, New York, US

• Led global acquisition, integration, international commercialization, forecasting, and A&P planning for ThermaCare medical device.
• Delivered 150% international Thermacare sales growth across 9 markets within 2 years, including 3 new country launches.
• Led global cross-functional team of over 100 people in acquisition & integration planning for ThermaCare
• Rapidly synthesized consumer insights and messaging priorities to determine strategic imperatives
• Drove ThermaCare re-launch strategic plan, content and creative campaign execution, inspiring collaboration across marketing teams in 11 countries
• Led strategic evaluation for probiotics category adjacency entry for Centrum multivitamins franchise.

New York, New York, US

• Responsible for International Analgesic, Respiratory & Personal care ~$500MM portfolio.
• Accelerated 2003-2008 5 year sales CAGR from 1% to 8%. Championed international analgesic /Advil strategic vision and brand plans in highly competitive market. Inspired marketing teams across the globe in 17 Advil.
• Crafted & secured alignment for Advil Global expansion and investment strategy. Established brand strategy and synthesized launch best practices. Steered local marketing plan execution, capabilities development & plan.
• Created best practice learning and compelling creative campaigns. Collaborated with local marketing teams to drive strategic launch/re-launch activities in over 15 international markets. Resulted in share gains and.
• Recognized with 5 Global Marketing Excellence Awards: U&A research best practice, global analgesic consumer insight, comparative claims development, acquisition planning, and launch planning.

Brentford, Middlesex, GB

• Progressed with roles of increasing responsibility to develop comprehensive strategy, pharmaceutical sales & technical consumer/HCP marketing skills with significant P&L and brand management responsibility. Held.
• Brands: TUMS, Nicorette, Nicoderm CQ, Flonase, Gaviscon
• Led the creation of SmithKline Beecham's first global marketing training program
• Integral contributions to the analysis, acquisition and integration of Sterling Healthcare; responsible for 17 anti-trust filings; member of corporate integration team and led International business planning analysis.
• Pharmaceutical sales representative in California.

M.A. (Cantab), Mathematics

Master Of Mathematics, Mathematics And Theoretical Physics